Proven therapies lead to treatment targets in patients with hypertension and T2DM

Two eminent experts discuss the management of hypertension and type 2 diabetes mellitus (T2DM) using evidence-based therapies during a Boehringer-Ingelheim sponsored symposium in Kuala Lumpur.